التفاصيل البيبلوغرافية
العنوان:
Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings
المؤلفون:
Päivi Halonen , Tarja Ruuska , Matti K. Salo , Anne Mäkipernaa , Jorma Mattila
المصدر:
Medical and Pediatric Oncology . 40:148-154
بيانات النشر:
Wiley, 2003.
سنة النشر:
2003
مصطلحات موضوعية:
Hepatitis , Cancer Research , medicine.medical_specialty , Pathology , Cirrhosis , medicine.diagnostic_test , business.industry , Fatty liver , medicine.disease , Gastroenterology , Liver disease , Oncology , Liver biopsy , Internal medicine , Pediatrics, Perinatology and Child Health , Biopsy , Medicine , Siderosis , business , Liver function tests
الوصف:
Background During modern intensified therapy for childhood acute lymphoblastic leukemia (ALL) serum liver enzymes reach fairly high levels. Since no recent data on liver histopathology after therapy are available, we conducted a study of the subject. Procedure Liver biopsy specimens were evaluated and serum liver function tests and lipid profiles measured from 27 consecutive children, aged 3.5–17.6 years, treated according to the regimens for standard (SR) and intermediate risk (IR) ALL. Results None of the patients had entirely normal liver histology. Fatty infiltration was detected in 25 out of 27 (93%) and siderosis in 19 out of 27 patients (70%). Fourteen (52%) had both. Three (11%) also had mild portal and/or periportal fibrosis in addition to fatty change and siderosis. Fatty change was mainly microvesicular. Siderosis was in most cases grade II/IV to III/IV (in 16/19 or 84%). No hepatitis or cirrhosis was found. Serum total and LDL-cholesterol levels were higher in the patients with fibrosis than in the patients with fatty change (P = 0.036, P = 0.042) or with siderosis ± fatty change (P = 0.036, P = 0.042). In serial ALT measurements a value of 300 U/L or more was oftener reached in the fibrosis than in the fatty change or siderosis groups (in 33 vs. in 12 or in 4% of the measurements, respectively, P = 0.014, in Kruskall–Wallis test). Conclusions Microvesicular fatty change and siderosis are the main liver findings after current therapy for childhood ALL. Fibrosis occurs rarely. High values in serial serum ALT measurements repeatedly or a disturbed serum lipid profile may facilitate decisions about the need for a liver biopsy. Med Pediatr Oncol 2003;40:148–154. © 2003 Wiley-Liss, Inc.
تدمد:
0098-1532
DOI:
10.1002/mpo.10231
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ef349fb56fe22551c0b5cab7e0853e3 https://doi.org/10.1002/mpo.10231
Rights:
CLOSED
رقم الانضمام:
edsair.doi...........7ef349fb56fe22551c0b5cab7e0853e3
قاعدة البيانات:
OpenAIRE